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ABSTRACT
Major challenges facing clinicians treating severe burns are the lack of vascularization,
inadequate mechanical properties, and high infection rates of current treatments, ultimately
leading to poor wound resolution. Electrospun chitosan membranes (ESCM) have shown
promise in tissue engineering applications due to their drug loading ability, biocompatibility,
biomimetic nanofiber structure, and antimicrobial characteristics. This work aims to modify
ESCMs for improved performance in burn wound applications by incorporating elastin and
magnesium nanoparticles (MgNP) to improve mechanical and bioactive properties. The
following ESCMs were made to evaluate the individual components’ effects; (C: chitosan, CE:
chitosan-elastin, CMg: chitosan-MgNP, and CEMg: chitosan-elastin-MgNP). Membrane
properties analyzed were nanofiber size and structure, elastin incorporation, magnesium loading
and in vitro release, mechanical properties, degradation profiles, and in vitro cytocompatibility.
Scanning electron microscopy (SEM) showed a uniform nanofiber structure among all groups.
Immunofluorescence staining confirmed the incorporation of elastin in CE and CEMg
membranes. Energy dispersive spectroscopy (EDS) showed the incorporation of magnesium in
CMg and CEMg membranes. CMg and CEMg exhibited burst-release behavior of ~6 µg/ml or
0.25 mM magnesium by day 3. CEMg showed no loss of tensile strength (~35 kPa) or Young’s
modulus (0.8 MPa) compared to C membranes (~25 kPa, 0.4 MPa). CE and CEMg showed a
higher degradation rate (30% remaining after 4 weeks) than C and CMg (50% remaining). In
addition, CEMg membranes showed significantly improved compatibility with NIH3T3 fibroblasts
compared to C and CMg. This work has demonstrated the successful incorporation of elastin
and magnesium into ESCMs and allows for future studies on burn wound applications.
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CHAPTER I
INTRODUCTION
CLINICAL PROBLEM
As the largest organ in the body, the skin serves an essential role as the first line of
defense and protects the inner organs from any physical and chemical harm [1]. Injuries to the
skin may cause loss of, or damage to, the layers of tissue. Loss of skin tissue can lead to
multiple clinical problems, including infection, loss of tissue function, and scarring [2].
One of the most common skin injuries is burns [3]. Burns can be caused by thermal,
chemical, or electrical stimuli [2]. All burn types cause damage to skin ranging from superficial
damage, including small blisters, to large-scale necrosis. Burn severity is dependent on the
depth of tissue damage ranging from superficial 1st degree burns to deep, dermal damage in 2nd
and 3rd-degree burns. In these severe cases, the damage can lead to discoloration of the skin,
loss of tissue or limb function, or systemic complications, which may lead to death. The external
exposure of these severe burns makes them prone to fluid loss/dehydration, high infection
rates, and inadequate wound resolution (scarring) requiring professional treatment [2].
The CDC reported that in 2011, near 500,000 patients received emergency burn
treatment [3]. Patients receiving care for burns experienced doubled costs and time in the
hospital compared to non-burn-related injuries [4]. Current therapies for treating severe burns
often require multiple treatments, increased attention, and high maintenance, which cause a
disproportionate amount of hospital spending. The USA spends approximately $20B per year on
wound treatments [5], [6].
Though burns are a relatively small portion of total injuries seen in the USA, they make
up a significant portion of accidental injuries in the household and workplace. Children and
elderly populations are the most likely victims of burn injury (24%) [3]. Though the survival rate
is high (>90%), burns often result in scarring and loss of function, which can lead to physical
1

disabilities and restricted movement. This usually affects daily life tasks, contributes to social
and economic hardships, and threatens mental health due to physical appearance/disabilities
[3], [7]. Injuries of this nature often result in loss of work time due to recovery time needed or
inability to perform specific tasks. It is estimated that the pay lost for burn patients who were
unable to work due to their injury totaled $5 billion [4].
Currently, grafting is the ideal treatment method for severe burn wounds [8]. Grafting
utilizes tissue from another part of the body and attaches it to the location of the injury. This is
done to provide healthy tissue to the local environment to improve the appearance and function
of the skin by providing a framework for new tissue to grow into. The presence of the graft helps
improve wound moisture balance, provides some barrier protection against infection, and
deposits tissue healing factors promoting wound resolution.
Autografts from the patient’s tissue are the go-to treatment for burns, but this treatment
requires a second surgery to harvest the graft tissue. Some patients may not have this option as
their burns can cover a significant portion of their body, minimizing the available skin for
grafting. To address this issue, allo- and xenografts are used, which come from human cadaver
donors or other species, respectively, which work in the same way. However, the implantation of
allo- or xeno- graft foreign tissue may induce an immune response that could decrease wound
healing efficacy and contribute to the damaged wound state [9]. Grafts also are subject to high
infection rates due to constant exposure to the external environment, further complicating
healing [10]. Grafting relies on passive healing as new tissue is expected to grow into the
provided graft framework. However, the timescale required may not be feasible for all patients,
especially those with severe burns who need rapid treatment to minimize fluid loss and
infection. Though functional and widely used, there are opportunities for researchers to improve
the grafting treatment’s healing capabilities and wound resolution.
Researchers have since improved upon the grafting techniques by developing and using
skin substitutes [11]. These substitutes come in cellular/acellular, natural, or synthetic
2

biomaterials [8]. Products range from the acellular human dermis mimicking materials to cocultured skin cells on natural or synthetic matrices. These treatments are intended to improve
grafts’ passive healing by providing the wound with an extracellular matrix-like scaffold to
accelerate healing and wound resolution. Usually fabricated in a lab, these products minimize
the need for a 2nd surgery, compared to autografts, and avoid the use of foreign tissue and the
immunogenic response elicited, compared to allo- and xenografts. Polymeric materials like
collagen, hyaluronic acid, and nylon are common materials to fabricate readily available
treatments [8], [12].
Though these products have shown great promise for widespread clinical application,
some obstacles limit their widespread clinical use. Many skin substitutes have caveat
instructions or are technique-dependent to optimize healing performance [8], [13]. These
treatments suffer from inflammatory foreign body response, lack of vascularization and nutrient
supply, inadequate mechanical properties, poor tissue integration, high cost, and unfavorable
scarring outcomes [14], [15]. Addressing these issues may allow for therapies with improved
healing capabilities, reduced scarring, and improved accessibility. A treatment that requires less
time and maintenance (both in production and in application) while providing increased healing
capabilities would improve patient outcomes and reduce the financial strain on both clinics and
patients.
To improve upon the currently available skin substitute burn treatments, many criteria
should be considered to ensure long-term efficacy and accessibility, including
biocompatibility/bioactivity of the material, mechanical properties for both handling and healing,
and accessibility to the public. The material of choice should not induce any additional
inflammation or infection when administered to the burn wound. The treatment should also be
able to induce active healing to promote improved wound resolution. A popular method of
incorporating bioactivity into treatments is the addition of bioactive chemicals to target specific
growth/healing promoting pathways [14]. A common target is the promotion of new blood vessel
3

growth to provide the local environment with nutrients and cells needed to begin the healing
process [16], [17], [18]. Burns that reach the dermis will damage any vasculature in the area [2].
Without proper growth of new blood vessels, the wound is at risk of infection, tissue necrosis,
scarring, and overall poor healing [19][20].
The mechanical properties of skin substitutes have been shown to greatly influence their
efficacies in regenerative medicine [21]. These treatments require specific mechanical
properties to ensure they are not damaged in handling or after application. Once applied, the
treatment will be influenced and altered by the surrounding shear forces of growing tissue. The
material must be robust enough not to be displaced by the ingrowing tissue. However, if the
material is too robust, it will deter cell infiltration and may not match its surrounding
environment, leading to growth abnormalities. Stiffness and strength will influence cell
morphogenesis and gene expression, both of which heavily affect wound healing and wound
resolution [21], [22].
There has been much research on burn treatments using natural materials like collagen,
silk, and other synthetic polymers to make fibrous, sponge, or foam treatments [14], [23].
Electrospinning is an increasingly popular fabrication tool due to its versatility and variety in
polymeric materials, the shape of scaffold/membrane created, and the quick production process
[24]. Nanofibrous scaffolds are frequently used due to their high surface-volume ratio, high
porosity, and similarity to the natural extracellular matrix. These factors contribute to high cell
infiltration and proliferation rates, ability to be modified, and eventual ingrowth of natural tissue.
Chitosan is a biodegradable, biocompatible polycationic polysaccharide similar in
structure to hyaluronic acid, commonly found in the natural extracellular matrix [25]. This
material may have similar effect to hyaluronic acid in promoting fibroblast and keratinocyte
growth and migration and promoting angiogenesis [26] [27]. Research has shown that chitosanbased materials promise burn wound applications due to many pro-healing factors [28]–[31].
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Many of the properties of chitosan align with the needs for burn wound treatments,
including its biocompatibility, antimicrobial/anti-inflammatory effects, and pro-healing
characteristics. However, current chitosan-based materials' healing efficacy and material
properties need to be improved upon before they see widespread clinical use.
This work aims to evaluate the effect of elastin and magnesium incorporation into ESCM
as a potential use for burn wound treatment. Elastin was selected for incorporation because it is
the second most common component in the extracellular matrix and may improve membrane
mechanical properties and cellular interaction [32]. Magnesium was selected for incorporation
because it has been shown to enhance wound healing in the skin via the stimulation of vascular
endothelial growth factor resulting in the increased presence of pro-healing macrophages at
earlier time points than typically expected [33], [34]. This component will act as a chemotactic
signal, promoting cell migration of cell lines vital to tissue regeneration (fibroblasts and
endothelial cells) [35], [36].
The incorporation of elastin and magnesium into electrospun chitosan membranes may
improve their performance for burn wound applications. If successful, this treatment may
provide healing capabilities to regenerate burn wounds that have yet to be seen in clinical
practice.
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CHAPTER II
LITERATURE REVIEW
Skin and Burn Injuries
The skin is composed of three main layers, with differing cellular/matrix compositions
and functions within each layer (Figure 1) [1]. The outermost layer, the epidermis, acts as the
shield to the outside environment and primarily consists of keratinocytes. Keratin and dead
keratinocytes make up the dense, outer layer serving as the first line of defense against
pathogens and creating the vital epidermal water barrier [37]. At the bottom of the epidermis lies
the Stratum basale, which separates the upper layer from the inner dermis layer.

Figure 1: Schematic of human skin tissue layers [38].

The dermis layer makes up most of the volume of the skin tissue and is therefore
responsible for the bulk properties associated with skin, including its elasticity and strength [1].
Fibroblasts, vasculature, hair, connective tissue, nerves, and collagen are some of the
components of this layer. Fibroblasts make up most of the cellular volume in the tissue. These
cells exude collage fibers which make up the extracellular matrix (ECM) of the dermis.
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Surrounding vasculature, nerves, hair, and connective tissue are contained in the dermis and its
dense collagen matrix. Because of these many different components, the dermis has multiple
functions, including providing blood to surrounding tissue, sensing touch/pain, and providing
mechanical protection of underlying organs.
Because the skin is constantly subject to the outer environment, it can become damaged
from various stimuli, including chemicals, radiation, excessive heat, or force. Burns are among
the most common skin injuries [3]. Burns can be caused by thermal, chemical, or electrical
sources [2]. Though occurring by different mechanisms, all the types of burns cause similar
damage to the skin ranging from superficial damage (including blisters) to severe necrosis of
large amounts of tissue. In extreme cases, this can lead to skin discoloration, loss of tissue/limb
function, or death.
Burn severity (1st – 4th degree) is classified by the depth of damage into the skin [2].
First-degree burns only damage the superficial epidermis, while 2nd and 3rd-degree burns go
through the epidermis and deep dermis/subcutaneous layer, respectively. Though superficial
burns may usually be treated with at-home remedies or over-the-counter treatments, more
severe burns require professional attention.
Damaged skin tissue causes significant changes in the homeostatic regulation of the
local environment and beyond. As the local tissue is burned, it will be subject to extreme
fluid/blood/tissue loss and become exposed and susceptible to infection [10], [39]. If these local
changes and damage are significant enough, the patient’s cardiovascular, respiratory, and
immunological systems’; functions can be disrupted [2]. Cardiovascular function is severely
impaired due to blood loss from damaged vasculature, inducing hypotension and reducing
cardiac performance. An inflammatory response in the lungs can also be generated, resulting in
bronchoconstriction and impaired breathing ability. The patient’s overall immune response may
also be decreased due to significant cell and protein loss, increasing susceptibility to other

7

diseases [2]. All these induced systemic responses make the original problem, the burn, more
challenging to heal.

Wound Healing
Generally, the wound healing process can be summarized in 4 stages: hemostasis,
inflammation, proliferation, and maturation [40]. After an injury, the body must first minimize fluid
loss via clot formation at the wound. Blood vessels constrict, limiting flow, while cytokines trigger
the coagulation cascade forming a clot. Following hemostasis, the chemotactic signals from
inflammation brings in macrophages and neutrophils to clean the injury site of pathogens and
debris.
New cells may now enter the cleaned injury site to repopulate the tissue void. These
cells include fibroblasts, smooth muscle, and keratinocytes [40]. Fibroblasts will work to lay
down collagen, rebuilding the structure of the new dermis layer. Vascularization of the new
tissue also occurs via endothelial cell recruitment. This process is crucial as it will provide new
routes for new cells to enter, as well as oxygen and nutrient delivery. The proliferation stage
may take weeks to allow the cells to migrate and begin to grow, depending on the extent of the
injury [40]. The maturation/remodeling stage sees increased collagen deposition, and
subsequently, increased mechanical properties [40]. Unfortunately, though, these mechanical
properties (and overall tissue quality) will never reach the level of healthy, uninjured tissue due
to limitations of wound healing.
However, burns have differences in the stages of wound healing compared to the
traditional model. Though the inflammation stage is similar, the proliferative and remodeling
stages can be prolonged and dampened, causing inadequate wound resolution and scar
formation [39]. In addition, deep burns damage melanocytes, causing hyperpigmentation of
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healed skin and unsatisfactory wound resolution. Other factors of burns like fluid loss/demand,
infection, and scar formation also influence the outcome of wound healing [39].

Grafts
The most common treatment for burns is skin grafts [8], [41]. This skin treatment has
received extensive interest and use throughout history, resulting in the modern form of skin
grafts that we see today. Grafting provides damaged tissue with healthy skin tissue to provide a
"“head start" “on the wound healing process. The healthy tissue will provide blood flow,
protection, mechanical stability, and cells that accelerate the wound healing rate. The skin graft
is cut to maximize the area covered using specific tools.
The source of the skin graft determines its classification: autografts from the patient’s
skin, allografts from a human donor’s skin, and xenografts from another species [41]. Autografts
are ideal for small to medium semi-severe burns and are renowned for their compatibility with
the patient and successful healing. However, in specific scenarios, the patient may not be able
to provide enough skin to produce an autograft as a second surgery is needed to explant the
graft tissue. For example, severe burn patients with extensive burns that cover much of the
body may not have enough healthy skin to provide for an autograft.
To address this issue, allo- and xenografts are used. Instead of the patient’s own body,
allografts are taken from other human donors, and xenografts are derived from other animal
species. Though the burn patient will not be subject to surgery for tissue removal, the
implantation of allo- or xeno- graft foreign tissue may induce an immune response that could
decrease wound healing efficacy and contribute to the damaged wound state [9],[41]. Because
of this immune response, these treatments are given with immunosuppressants to reduce graft
rejection, though this may not be an option for patients already immunocompromised due to
accompanying disease or therapy [14].
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Clinicians and researchers looked to target these drawbacks to address the
shortcomings associated with grafting to improve burn wound resolution.

Skin Substitutes
Due to a need for a natural skin-mimicking treatment, researchers have investigated
engineering skin substitutes [8], [14], [23]. Ideally, clinicians need a treatment that does not rely
on once-living tissue, does not induce an immune response, and can provide similar or better
healing than currently available grafts. The need for a second surgery (autograft) or potentially
immunogenic tissue graft (allo-, xenograft) can be avoided by implementing tissue engineering
fabrication strategies to fabricate a material for treatment. These materials can then be
specifically chosen and modified not to induce immune responses and promote healing. New
emerging technologies have opened new pathways for skin substitutes, allowing for unique
techniques, combinations, and materials for burn wound treatment fabrication. These
technologies range from advancements in analysis, fabrication, and testing techniques that
ultimately lead to more robust, efficacious products through more detailed research and
application [42].
Skin substitute is a blanket term given to any tissue engineered skin treatment intended
for the same function as an auto/xeno/allograft. These engineered constructs can be
manufactured from different materials (artificial, biological, or synthetic) that act as skin ECM
mimicking templates and may involve cells and growth factors/therapeutics to promote healing
[23]. Many skin substitutes are available, which vary significantly in composition,
advantages/drawbacks, and overall performance.
Acellular skin matrix treatments, like Biobrane®, utilize different materials, like a nylon
mesh in combination with silicone, to mimic the dermis and epidermis, respectively [8].
Biobrane® reduces the risk of an induced immune response due to its acellular design. This
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treatment can attach to the injury location with porcine-derived collagen-1 peptides bonded to
the nylon and silicone [13].
Though still readily used in practice, the treatment must be carefully administered and
comes with many caveats that health professionals must consider. Biobrane® is unable to act
as a definitive treatment for deep burn injuries, which require both epidermal and dermal
healing, though it is advertised as such [13]. This treatment also has complications dealing with
infections, which requires medics to thoroughly clean the site before administration – so much
so that patients often must be anesthetized due to the intensity of scrubbing [13]. Therefore, the
inadequate application is a risk that may result in reduced integration of the treatment and
infection, resulting in poor wound resolution.
Cellular skin substitutes include and depend on cells within their matrices to support
healing. These treatments, like TransCyteTM, take the concept that Biobrane® utilizes (a nylon
and silicone mesh) and includes neonatal foreskin-derived fibroblasts. [8]. These cells are
seeded onto the mesh and, when implanted, will output chemokines and matrix proteins needed
to induce local healing that acellular treatments would find difficult to replicate. Though
promising, the inclusion of allogenic cells may also induce an immune response which may
further harm the wound. In addition to this drawback, TransCyteTM usage is limited as it is only
considered a temporary treatment due to its lack of long-term efficacy [8].
Immunogenic complications are brought on by using non-native cells and matrix
components [9]. Though the inclusion of cells may provide functions that are otherwise difficult
to recapitulate, they may be worsening the state of injury through host rejection [43]. This will
occur when the body recognizes foreign cells, or matrix components, with mismatched major
histocompatibility complexes (MHCs), often occurring in allogeneic and xenogeneic grafts [14].
This is an acquired immune response involving hyperresponsive CD8+ T cells, which emerge
after a burn injury [44]. These immune cells respond to antigens on the foreign implant and work
to prevent the graft from integrating and eventually destroy it. The overall effect of this graft
11

rejection is an upregulated inflammatory response that will destroy donor cells, reject treatment,
and worsen injury [45].
However, cells are not the only concern for an induced immune response. For example,
a commonly used acellular dermal regeneration treatment, Integra, requires crosslinking of
collagen and a glycosaminoglycan to function. This crosslinking has been shown to induce a
more significant foreign body reaction and recruit more giant cells, which will impede its healing
capabilities [46].
To bypass these responses, researchers are forced to put patients on
immunosuppressants, consider stem cell usage, or forego the use of non-native cells altogether
[14] [47]. Though the inclusion of cells may increase the patient’s healing response, an acellular
treatment that could provide the same healing capabilities would reduce the risk of host
rejection. An alternative would be to harvest, grow, and apply the patient’s cells to the treatment.
Still, this option may be difficult considering the immediate demand for a severe burn and the
time needed to fabricate the treatment.
Other cellular treatments, like Laserskin and Hyalograft 3D, make use of mimicking
natural matrix proteins. These treatments are autologous epidermis and dermis treatments,
respectively, which are structurally similar. Both utilize hyaluronic acid, a significant matrix
component in skin tissue, and include keratinocytes or fibroblasts for epidermis and dermis
treatment, respectively [12]. Unfortunately, these treatments are relatively costly, restricting their
availabilities and usage among patients.

Tissue Engineering Skin: Considerations
Many challenges remain before an ideal burn wound treatment is achieved. There are
many variables to consider when designing a treatment, including fabrication methods,
materials, etc. However, there are key drawbacks that currently available skin substitutes suffer
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from, and other tissue engineered treatments should consider to improve burn wound
resolution.
Burnt tissue suffers from fluid loss and damaged vasculature. The healing process
begins with and relies on blood vessels delivering cells, oxygen, and nutrients. Without restoring
this vasculature, the healing process will suffer [48],[19],[20]. For example, Integra, a skin
substitute, has been reported to take three weeks until host vessels begin invading the
treatment matrix [49]. Many studies in the literature have isolated and shown the impact that
vascularization has on overall healing outcomes [49]–[51]. For example, one study used
genetically modified keratinocytes to overproduce vascular endothelial cell growth factor (VEGF)
to improve vascularization [50]. Results showed that upregulation of the pro-neovascularization
factor, VEGF, enhanced endothelial cell migration, potentially improving large-scale healing.
Another study utilized adipose-tissue-derived microvascular fragments within their treatment
matrix to improve vascularization on Integra treatments [49]. The goal of this study was to
reduce the time necessary for an adequate amount of vascularization to occur. This was found
to be successful as treatments with microvascular fragments had improved implant integration
compared to those matrices without.
In addition to the need for enhanced vascularization, the mechanical properties of the
treatment should also be considered from both a healing and application point of view. Within
the healing tissue, the treatment’s presence and mechanical properties will influence the
surrounding tissue’s growth and subsequent healing [21], [22]. Engineers must also consider
the response of the treatment to its changing environment, as it may influence the treatment’s
performance. Finally, the handleability should be considered for easy application with the
clinician in mind. Burns can be complicated and cover abnormal, hard-to-reach areas of the
body. The treatments for these burns may have to be held in place for hours-days and must
therefore be malleable but robust.
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It is crucial to optimize the mechanical properties of the skin substitute to guide tissue
development in a favorable direction. Often, applied skin substitutes never recover the
mechanical properties once seen in healthy skin, which is not ideal and increases scarring [52].
By improving the mechanical properties of the skin substitutes, we can better control the
development of new tissue into the wound to improve patient healing outcomes.

Electrospinning
Electrospinning has become one of the most popular tools in tissue engineering for cell
scaffold fabrication [24]. The fabricated nanofibers mimic the natural extracellular matrix and
have a high surface area to volume ratio, promoting cell infiltration and proliferation.
Researchers have benefited from the versatility of polymers able to be electrospun by utilizing
different electrospinning polymer (and copolymer) solutions making for a wide variety of new
biomaterials. The membrane’s nanofibrous structure mimics the natural extracellular matrix.
Polymer, and polymer combinations, can also be specifically chosen to tune mechanical and
degradation properties. Electrospinning utilizes control over electrostatics and polymer solution
viscosity/surface tension to extrude nanofibers from said solution onto an oppositely charged
collecting plate/mandrel. This fabrication technique has a quick turnaround, but the quality is
very sensitive to many parameters, including humidity, temperature, and spinning apparatus.

Chitosan
Chitosan is a biodegradable, biocompatible polycationic polysaccharide similar in
structure to hyaluronic acid, commonly found in the natural extracellular matrix [25], [53], [54].
Hyaluronic acid is known to improve fibroblast and keratinocyte growth and migration as well as
promote angiogenesis, and chitosan may have the same effect [26] [27]. In addition to its
structural similarities to hyaluronic acid, chitosan exhibits good mechanical and antimicrobial
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properties, which are essential for tissue integration and preventing infection, respectively [53].
Chitosan is derived from chitin, which comes from the exoskeleton of shellfish. Therefore, this
material is cheap and readily available worldwide if translation to mass production was to be
considered.
Some of chitosan’s natural properties are advantageous for burn wound applications.
The material is able to improve on the first two stages of burn wound healing by 1) promoting
quicker clotting and retention of fluid, 2) modulating the inflammatory response, and 3)
decreasing the rate of infection [30]. Chitosan has just begun to see interest in the skin tissue
engineering field and in many forms/fabrication methods [28]. Some chitosan burn treatments
come in the form of hydrogel, dressing, gel, or fibrous templates [30], [55], [56]. It is often paired
with an additional bioactive component to aid in healing; some examples include silver or
another natural polymer [44]–[46]. When combined with natural polymers, like collagen and
elastin, chitosan materials have increased mechanical and biological performance [28]. Many in
vivo studies suggest chitosan and chitosan-based materials can be used in burn wound
applications [29], [60], [61]. However, many chitosan-copolymer and chitosan-drug
combinations have yet to be tested, some of which may be useful for healing burn wounds.
Electrospun chitosan membranes have shown promise when used in guided bone regeneration
applications [57]. Their bioactivity and mechanical properties can also be modified by adding
other polymers or side groups [62],[63].
We believe that electrospun chitosan membranes have the most potential for burn
wound applications when combined with another copolymer to gain added mechanical and
biological traits. In addition, it is essential to take advantage of the electrospun material’s drugdelivering ability to improve wound healing further. Therefore, we aim to incorporate elastin into
our electrospun chitosan membranes to improve the mechanical properties and increase cell
infiltration within the material. We will also load the material with magnesium to promote
vascularization, increase nutrient and oxygen delivery, and improve healing outcomes. This
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novel, electrospun chitosan-elastin copolymer loaded with magnesium material may be able to
perform simultaneous functions (like preventing infection, promoting tissue growth, retaining
moisture, and increasing vascularization) that currently available treatments are incapable of.

Elastin
Elastin is the second most common component in the extracellular matrix; only collagen
is found in higher abundance [32], [64]. Its unique elastic mechanical properties function in
body regions where stretching and pulling are necessary, like most connective tissue [32]. This
natural polymer is a protein with unique ‘relaxed’ and ‘stretched’ states that give rise to different
mechanical properties depending on the need at that specific spot in the body [64]. Its traits are
vital for organ functions which need to be highly mobile but strong and durable, like breathing in
lungs and opening/closing in aortic valves [65], [66]. The incorporation of elastin into cell
scaffolds has recently interested engineers due to the added benefits of improved cell adhesion
and cell growth [62], [67], [68]. In addition, naturally derived polymers provide some
functionalization to polymer scaffolds that more closely mimics the natural ECM duty as both a
structural and functional support for the environment. Currently, there is little research in the
literature on chitosan-elastin copolymer electrospun scaffolds for skin wounds.

Magnesium
Magnesium, one of the most important and abundant ions in the human body, is
responsible for a multitude of daily functions. Lack of magnesium has been associated with old
age, diabetics, kidney disease, intensive care unit patients [69]. Concerning wound healing,
magnesium plays multiple background roles in the healing process as a cofactor in many
interactions. Magnesium has been shown to improve wound healing in the skin via the
stimulation of vascular endothelial growth factors, resulting in the increased presence of prohealing macrophages at earlier time points than normally expected [33], [34]. Furthermore,
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magnesium acts as a chemotactic signal, promoting cell migration of cell lines vital to tissue
regeneration (fibroblasts and endothelial cells) [35], [36].

AIMS
The goal of this work is to establish a protocol incorporating elastin and magnesium into
ESCMs and analyze physical, chemical, and biological characteristics. This research will
provide fundamental, translational knowledge of how ESCMs can be modified to treat burn
wounds.
Aim #1: Establish an electrospinning protocol and apparatus for reproducible fabrication
of membranes, as well as the characterization of physical and chemical properties.
The following groups of ESCMs will be made to evaluate the individual components’
effects; (C: chitosan, CE: chitosan-elastin, CMg: chitosan-MgNP, and CEMg: chitosan-elastinMgNP). The characterization will include scanning electron microscopy (SEM) imaging to
examine fiber morphology and diameter, tensile testing to determine mechanical properties,
energy dispersive spectroscopy (EDS) for magnesium incorporation verification, and
immunofluorescence staining for elastin incorporation.

Aim #2: Characterize the membranes’ in vitro degradation and magnesium release
profiles. Assess cytocompatibility with NIH-3T3 fibroblasts.
Once characterized, the membranes will have degradation profiles assessed over a 4week study in simulated body fluid (SBF). Magnesium release behavior will be tested by
collecting and analyzing eluants from membranes in PBS over 1-week. Membrane samples will
have cytocompatibility tested in vitro with fibroblasts (NIH 3T3) over five days. Cultured
membrane samples will also be stained and imaged using fluorescence Live/Dead staining.
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CHAPTER III
EVALUATION OF MAGNESIUM AND ELASTIN INCORPORATION INTO
ELECTROSPUN CHITOSAN MEMBRANES FOR SKIN WOUNDS

ABSTRACT
Major challenges facing severe burn wound treatments are the lack of vascularization,
inadequate mechanical properties, and high infection rates, ultimately leading to poor wound
resolution. Electrospun chitosan membranes (ESCM) have shown promise in tissue engineering
applications due to their drug loading ability, biocompatibility, biomimetic nanofiber structure,
and antimicrobial characteristics. This work aims to modify ESCMs for improved performance in
burn wound applications by incorporating elastin and magnesium nanoparticles (MgNP) to
improve mechanical and bioactive properties. The following ESCMs were made to evaluate the
individual components’ effects; (C: chitosan, CE: chitosan-elastin, CMg: chitosan-MgNP, and
CEMg: chitosan-elastin-MgNP). Membrane properties analyzed were nanofiber size and
structure, elastin incorporation, magnesium loading and in vitro release, mechanical properties,
degradation profiles, and in vitro cytocompatibility. Scanning electron microscopy (SEM)
showed a uniform nanofiber structure among all groups. Immunofluorescence staining
confirmed the incorporation of elastin in CE and CEMg membranes. Energy dispersive
spectroscopy (EDS) showed the incorporation of magnesium in CMg and CEMg membranes.
CMg and CEMg exhibited burst-release behavior of ~6 µg/ml or 0.25 mM magnesium by day 3.
CEMg showed no loss of tensile strength (~35 kPa) or Young’s modulus (0.8 MPa) compared to
C membranes (~25 kPa, 0.4 MPa). CE and CEMg showed a higher degradation rate (30%
remaining after 4 weeks) than C and CMg (50% remaining). In addition, CEMg membranes
showed significantly improved compatibility with NIH3T3 fibroblasts compared to C and CMg.
This work has demonstrated the successful incorporation of elastin and magnesium into ESCMs
and allows for future studies on burn wound applications.
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INTRODUCTION
The USA spends ~$20B per year on wound treatments, including severe burn injuries
requiring emergency room treatment and hospitalization [5]. Nearly 400,000 patients
experienced severe burns that needed emergency treatment in 2018 [70]. Though most patients
survive, those with severe damage may have permanent loss of function or scarring. In addition,
the disability and disfigurement that accompanies severe burns (2nd/3rd degree) affect patients’
daily life tasks and contribute to social and economic hardships [3], [7].
Standard treatment for severe burns is the use of auto-, allo-, or xeno- grafts [8], [41].
This treatment’s mechanism relies on explanted skin tissue covering and acting as a platform
for new tissue growth. Skin grafts provide the damaged environment with protection, cells, and
nutrients needed to improve healing [41]. However, these treatments are still exposed to the
external environment and are prone to infection [10]. Grafting results in inadequate aesthetics
due to hyperpigmentation and disfigurement, impacting the patient’s social and economic wellbeing [5], [7]. Autografts may not be an option for some patients as severe burns often cover a
significant portion of skin, leaving little to explant. Allografts and xenografts avoid the issue of
harvesting tissue from the patient, but because they are derived from other people or animal
sources, they may induce unwanted inflammation caused by an immune response [9], [14]
There has been much research to overcome these challenges by developing various
tissue engineered burn treatments consisting of acellular or cellular, ECM-mimicking tissue
templates [8], [11]. These ‘skin substitutes’ improve the passive healing of skin grafts by
providing the native tissue with native ECM-like matrices, usually in combination with prohealing biological agents, that influence surrounding tissue to promote growth.
Though these products show promise, their use is limited due to poor mechanical
properties, lack of tissue-template integration, inadequate vascularization, and high cost
associated with luxury treatments [15], [9], [25]. Skin substitutes’ performance are highly
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technique sensitive; they are often mishandled during application and require increased
cleaning and attention from caregivers [8], [13], [71].
Addressing these drawbacks in a new treatment may improve the overall wound
resolution and outcome of patients with burn wounds. Designing a skin substitute begins with
selecting a base material that will influence many mechanical and biological properties. For
example, the biomaterial chitosan has been explored as a burn wound treatment [28], [30].
Chitosan is a readily available biomaterial derived from the exoskeleton of crustaceans that has
shown promise for tissue engineering applications [25], [53]. Some of its natural properties, like
clot promotion, anti-inflammatory, and antimicrobial properties, are advantageous for burn
wound applications [30]. Alongside these properties, chitosan can act as a drug delivery vehicle
providing an additional opportunity to influence healing [28]. Chitosan treatments are usually
delivered in a hydrogel or dressing accompanied by other bioactive polymers or agents [28],
[30], [31]. Though various combinations of chitosan-copolymer and chitosan-drug burn
treatments have been explored [30], [31], [58], [60], the material’s versatility allows for many
therapeutic combinations that have yet to be tested, which may further improve healing.
Past studies have demonstrated electrospun chitosan membranes (ESCM) are
successful in guided bone regeneration applications and can act as drug delivery vehicles [57],
[72], [73]. Because of their biomimetic nanofiber structure and potential for drug delivery, these
membranes may be further modified to help enhance the bioactivity of the membranes to
support skin healing and re-epithelialization that would lead to improved burn wound healing
performance.
Elastin was selected to be incorporated into ESCMs because it is the second-most
abundant matrix component found in the body, its elastic mechanical properties, and its ability to
support cell adhesion and growth [32], [68]. The elastin-chitosan composite structure may
provide an excellent biomimetic template for tissue engineering skin and may be more attractive
to infiltrating cells than chitosan alone. The inclusion of elastin in a chitosan electrospun
20

membrane may improve the mechanical properties to better facilitate healing in skin, compared
to chitosan alone [28], [68].
Magnesium was selected to be incorporated into the ECM because it is a commonly
found ion in the body, plays a role in many processes across the body, including vascularization
[69]. Magnesium concentration has been shown to act as a chemotactic signal for endothelial
cells and promote an early influx of pro-healing macrophages [36], [74], which may eliminate the
need to use expensive and hard-to-control growth factor delivery like VEGF.
This work aims to evaluate the physical, mechanical, degradation, and cytocompatibility
properties of electrospun chitosan-elastin copolymer membranes loaded with magnesium for
burn wound applications. It is believed that incorporating elastin and magnesium into ESCM
may improve their physical, chemical, and bioactive properties for improved healing
performance in burn wounds. Electrospun membranes were characterized for physical structure
and chemical composition and in vitro degradation, magnesium release, and cytocompatibility.

MATERIALS AND METHODS
Membrane fabrication
ESCMs were fabricated as previously described [57], [75], [62]. Briefly, a 5.5 (w/v)%
Chitosan (Primex, Iceland) (71% DDA, MW = 311.5 kDa) was dissolved in trifluoroacetic
acid/dichloromethane (TFA/DCM) (7:3) solution. This solution was electrospun at 27 kV
(Gamma High Voltage Research, USA) in a custom plexiglass box vented to a fume hood used
to make standard ESCM (C). To make chitosan-elastin (CE) electrospun membranes, 4(w/v)%
soluble, bovine-neck elastin “ES-12” (Elastin Products Company, Inc. Owensville, USA) added
to the chitosan-TFA/DCM solution just before spinning. Chitosan-MgNP (CMg) and chitosanelastin-MgNP (CEMg) membranes were made by adding 0.5 (w/v)% MgNP to C-TFA/DCM or
CE-TFA/DCM solutions, respectively. After spinning, all membranes underwent a
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triethylamine/di-tert-butyl dicarbonate treatment to remove residual TFA salts and improve
retention of fiber morphology in aqueous environments [73], [75]. Briefly, membranes were
soaked and mixed in a 10% (v/v) triethylamine/acetone solution for 24 hrs. After rinsing with
acetone for 2 hrs, three times, the membranes were transferred to a 0.1 g/mL di-tert-butyl
decarbonate/tetrahydrofuran solution and mixed for 48 hrs. Membranes were removed and
allowed to dry between nylon mesh sheets.

Magnesium Nanoparticle Synthesis
MgNP were fabricated using a protocol established by Zhou et al. [76]. Microwaveassisted spontaneous precipitation was used to create MgNP from a supersaturated biomimetic
fluid. Briefly, sodium bicarbonate, magnesium chloride hexahydrate, and monopotassium
phosphate are mixed in deionized water, then microwaved for 5 mins, and allowed to cool to
room temperature. This solution is poured into dialysis tubing (Spectra/Por® dialysis membrane;
MWCO: 3,500) and placed in 1 L of DI water, with water changes daily for three days. Dialyzed
contents are then removed from tubing, allowed to freeze overnight, and then lyophilized for 48
hrs.

Characterization
Scanning electron microscopy (SEM) and Energy-dispersive X-ray spectroscopy (EDS) analysis
Electrospun fibers' surface morphology among membrane groups was analyzed before
and after hydrophobic treatment by SEM (NOVA NanoSEM 650, FEI Company, USA) and EDS
analysis (Oxford Instruments NanoAnalysis, USA). Membranes were attached to a SEM stub
with double-sided, conductive tape and sputter-coated with 5 nm gold-palladium.
Images were taken between 500X and 5000X magnification. Images of three sample
locations per membrane and 20 fiber measurements per representative image of the membrane
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were taken to determine the uniformity of fiber morphology and average fiber diameter. Fiber
analysis was conducted using Image J Fiji – Image analysis software.
EDS data was collected to determine TFA salt removal from spun membranes before
and after the hydrophobic treatment via the F-peak. This will also be done to verify the
magnesium incorporation via the Mg-peak. Spectra will be analyzed via Aztec 3.0 software
(Oxford Instruments, UK).

Fourier Transform Infrared Spectroscopy
To verify the removal of TFA salts, attachment of hydrophobic group, and confirm elastin
incorporation, Fourier Transform Infrared Spectroscopy (FTIR) (Frontier Universal Attenuated
Total Reflection (ATR-IR) system with a diamond crystal, Perkin Elmer, Waltham, MA). TFArelated peaks were investigated at 720, 802, and 837 cm-1. Hydrophobic treatment-related
peaks would be found at 1370, 1529, 1688, and 2980 cm-1. And elastin-related peaks were
located at 1535 and 1655 cm-1.

Water Contact Angle Hydrophobicity Analysis
Water contact angle measurements (n = 3) (VCA Optima Measurements Machine, AST
Products, USA) were conducted on membrane groups to evaluate elastin and magnesium
incorporation's effect on the hydrophobic treatment.

Immunofluorescence staining for elastin incorporation verification
Single samples from membranes were qualitatively analyzed using indirect
immunofluorescence staining to verify elastin incorporation. Anti-elastin antibody (ab21610,
Abcam plc., Cambridge U.K.) was used as the primary binder to elastin and conjugated with
Alexa Fluor 488. Membranes were imaged using a fluorescence microscope.
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In vitro magnesium release
Discs were punched (diameter = 1 cm) out of CMg and CEMg membranes
(n=3/membrane type) and placed in 400 µL of PBS in 48-well plates to examine Mg ion release.
Membranes were incubated at 37°C, and supernatants were removed entirely and replaced at
days 1, 3, 5, and 7. Eluates were evaluated for Mg ion release using the QuantiChrom™
Magnesium Assay Kit (BioAssay Systems, Hayward, CA, USA)

Tensile testing
Changes in ESCM tensile properties due to elastin and Mg NP incorporation (n =
4/membrane type) were evaluated using an InstronTM tensile testing system (Model 4456,
Norwood, MA, USA). Membranes were punched into dog-bone shape specimens with 20 mm
gauge lengths and tested in tension using a 50 N load cell and an extension rate of 1 mm/min.
Data were used to analyze the total percent elongation, ultimate tensile strength (UTS), and
Young’s modulus of the different membrane groups.

In vitro degradation study
A four-week degradation study (n = 4) was conducted using simulated body fluid
(300µg/mL lysozyme type VI [MP Biomedicals, Illkirch, France] in 1X PBS) to elucidate
degradation profiles. Membranes were punched out into 1 cm discs and had original mass
recorded. Samples were placed in 400 µL of simulated body fluid in 48-well plates and had
solution changed every three days. Membranes were removed at weeks 1, 2, 3, and 4 and dried
in a desiccator for 48 hrs before recording the remaining mass. Degradation progress was
assessed by comparing membrane mass to original, undegraded membrane mass.
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Magnesium nanoparticle in vitro cytotoxicity
Cytotoxicity of the MgNP was evaluated in vitro using NIH3T3 fibroblasts (ATCC#CRL1658™). Two 96-well plates were seeded with 10,000 cells/well and allowed to adhere
overnight in standard complete culture medium (α-MEM with 10% FBS, 500 I.U./mL penicillin,
500 µg/mL streptomycin, and 25 µg/mL amphotericin-B). A serial dilution of MgNP in complete
medium was made ranging from a concentration of 10 mg/ml to 0.1 ng/ml nanoparticles/media.
This was used to replace the normal medium after 24 hr post-seeding (n = 6/dilution).
Cytotoxicity was assessed using CellTiter-AQ® assay(Promega, USA) at 24 and 72 hr postexposure to nanoparticle media.

In vitro cytocompatibility of membranes
NIH 3T3 fibroblasts (ATCC#CRL-1658™) were used to evaluate the cytocompatibility of
the membranes. Membranes (n = 5/group) were cut into 1 cm discs to fit the wells of a 48-well
plate. These discs were sterilized via ethylene oxide gas sterilization. The culture medium
consisted of α-MEM with 10% FBS, 500 I.U./mL penicillin, 500 µg/mL streptomycin, and 25
µg/mL amphotericin-B at 37°C. Cells were seeded at 3x10^4/membrane in 48-well plates and
evaluated for growth using the CellTiter-Glo® Luminescent Assay (Promega, USA) at days 1, 3,
and 5. A sample from each group was analyzed with fluorescent viability staining (LIVE/DEAD™
Stain, Invitrogen, USA) and imaged on a fluorescent microscope.

Statistical Analysis
All statistical analysis was done using the ‘Real Statistics’ plugin for Microsoft Excel.
Fiber diameter, tensile testing, water contact angle, and MgNP cytotoxicity results were
analyzed using one-factor ANOVA with Tukey HSD post hoc analysis (α = 0.05). Magnesium
release, degradation, and cytocompatibility results were analyzed using a two-factor ANOVA
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with Tukey HSD post hoc analysis for interactions between membrane groups and time (p
<0.05).

RESULTS
Fiber morphology and fiber diameter analysis
SEM imaging showed uniform and smooth fiber morphology across all membrane
groups (Figure 2). There were small amounts of fiber fusion but no evidence of fiber beading. In
addition, there was no difference in fiber morphology when imaging either side of the membrane
(facing collector vs. facing syringe).

Figure 2. Representative SEM images were taken at 5000x of post- treated C, CE, CMg, and
CEMg membranes (A – D, respectively).

Statistical analysis of fiber diameter found that CE (p = 0.0005), CMg (p = 0.0205), and
CEMg (p = 4x10-14) membranes had significantly larger fiber diameters than the control chitosan
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(C) membranes (Figure 3). Additionally, the CEMg membrane's fiber diameter was statistically
different from CE (p = 1x10-6) and CMg (p = 8x10-9).

Figure 3. Average fiber diameter (n = 3) of membrane groups. ‘ * ’ denotes significant difference
(p < 0.05).

EDS analysis for magnesium incorporation verification.
EDS analysis confirmed successful magnesium incorporation (Figure 4). Magnesium
presence is confirmed with the magnesium peaks seen in spectra. Visualization of magnesium
as green dots in overlayed image shows an even distribution.

27

Figure 4. EDS spectra analysis of post-treated CMg (A.) and CEMg (B.) Green color indicates
magnesium presence.

FTIR analysis
FTIR analysis of the C, CMg, CE, and CEMg membranes is shown in Figure 5. All
membrane groups lacked peaks at 720, 802, and 837 cm-1 characteristic of TFA salts,
confirming successful salt removal. The CE and CEMg groups have differences in peaks at
wavenumbers associated with the elastin amide (1535 and 1655 cm-1).
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Figure 5: FTIR spectra of C, CE, CMg, and CEMg membranes. A black box surrounds the TFArelated peaks (720, 802, and 837 cm-1). Hydrophobic treatment-related peaks are individually
labeled with black lines (1370, 1529, 1688, and 2980 cm-1). Elastin-related peaks are marked
with a dashed line (1535 and 1655 cm-1).

Water contact angle analysis
Results of the water contact angle measurements are shown in Figure 6. Results
indicated that all membrane groups were initially hydrophobic with contact angles greater than
90° as a result of the hydrophobic treatment. After 30s, the elastin-containing membranes
become hydrophilic with contact angles much less than 90° as compared to the non-elastincontaining membranes. Statistical analysis showed that CE and CEMg membranes were
significantly different than C and CMg membranes at t = 0s (p < 0.01) and at t = 30s (p < 0.001).
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Figure 6. Water contact angle measurements (n = 3/group). ‘ * ‘ denotes significant difference (p
< 0.01), ‘ ** ‘ denotes signicant difference (p < 0.001).

Immunofluorescence staining for elastin incorporation
Immunofluorescence staining of CE and CEMg membranes confirmed successful elastin
incorporation into ESCMs (Figure 7). The green color indicates immunostained elastin.

Figure 7. Representative immunofluorescence images of elastin in CE (A.) and CEMg (B).
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In vitro magnesium release
The 7-day magnesium release study results are shown in Figure 8. Each 1-cm disc
membrane released approximately 6 µg/mL or 0.25 mM magnesium within 24 hrs. A two-factor
ANOVA identified significant interactions for sample groups (p = 9x10-6) and time (p = 1.9x10-10)
on magnesium release. A one-factor ANOVA with Tukey HSD posthoc analysis for Day 1
showed CMg membranes were significantly different than C and PBS groups (p = 0.0184, p =
0.0149, respectively). The CEMg group’s magnesium release was also significantly different
compared to C and PBS (p = 0.0082, p = 0.0067, respectively). No magnesium was released on
days 3, 5, or 7.

Figure 8. Magnesium release (n = 3/group) from CMg, CEMg, and negative controls C and PBS
blank taken at days 1, 3, 5, and 7. ‘ * ’ denotes significant difference (p < 0.05). ‘#’ denotes
significant difference (p < 0.01).

Tensile testing
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The result of mechanical tensile testing of the membranes is shown in Figure 9. Oneway ANOVA was used to identify differences in UTS, modulus, and percent elongation among
membrane types. The CE membranes had significantly greater UTS (~50 kPa) as compared to
C (p = 3x10-4), CMg (p = 0.0012), and CEMg (p = 0.0014) (Figure 9A). Both CE (p = 0.052) and
CMg (p = 0.039) membranes (~1 MPa) showed differences in moduli compared to that of C (0.5
MPa) (Figure 9B) (p < 0.05). CEMg membranes had a modulus of ~0.75 MPa. Max extension
was significantly impacted by the inclusion of elastin and magnesium (Figure 9C). CMg (p =
7x10-4) and CEMg (p = 0.002) had significantly decreased extension compared to that of C.
Additionally, CE max extension was also found to be different than CMg (p = 0.029).

Figure 9. Ultimate tensile strength in kPa (A.), Young’s modulus in MPa (B.), and Maximum
extension (C.) of membranes are shown. *: denoted significant difference (p < 0.05)

Degradation profiles of membranes
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Results of the in vitro degradation study are shown in Figure 10. All membranes showed
significant decreases in mass over the 4-week test period. Over the initial two weeks, the
elastin-containing membranes tended to show more mass loss than non-elastic membranes,
especially after the initial 2 wk test period. By week 4, The CE and CEMg membranes showed
approximately 70% loss in mass compared to only 50% loss of the C and CMg membranes.
Statistical analysis using a two-way ANOVA showed significant interactions among
membrane types (p = 3x10-29) and over time (p = 7x10-111) affecting membrane degradation (p <
0.05). One-way ANOVA within each timepoint was conducted and found that at week 2, CEMg
was significantly different compared to C (p = 0.007), CE (p = 0.0014), and CMg (p = 0.00037)
sample groups. And at week 3, CE was found to be different compared to C (p = 0.039) and
CMg (p = 0.023). No differences were found at weeks 1 and 4.

Figure 10. Degradation profiles of membrane groups. Membrane % remaining is a comparison
of current mass vs. undegraded membrane mass. ‘*’ denotes significant difference (p < 0.05).

Magnesium nanoparticle cytotoxicity
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MgNP cytotoxicity results are shown in Figure 11. On Day 1, the viability of the cells was
not significantly reduced compared to controls by exposure to MgNP up until 1 mg/ml. The cells
exposed to 10 mg/ml MgNP exhibited a significant reduction in viability compared to all groups,
except 1 mg/mL, at day 1 (p < 0.01). After 3 days, the 10 mg/mL group was significantly
different from all groups (p < 0.01). The 1 mg/mL group had the biggest increase from day 1 to
3.

Figure 11. Absorbance from cytotoxicity assay after cell exposure to MgNP-doped media for 24
and 72 hrs. Data is normalized to media blank with no MgNP. Higher absorbance is associated
with a higher cell count.

In vitro cytocompatibility of membranes
Results of the cytocompatibility of the different ESCM groups with NIH3T3 fibroblasts are
shown in Figure 12. The two-way ANOVA indicated a significant difference among membrane
groups (p = 2x10-6) and cytocompatibility, but no interaction related to time. Further one-way
ANOVA within each timepoint identified differences in cytocompatibility among groups. On day
1, CE and CEMg membranes showed greater cytocompatibility than other groups, but only
CEMg groups were deemed statistically different from C (p = 0.032) and CMg (p = 0.012). On
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day 3, this trend continued with CEMg again being statistically different from C (p = 0.048) and
CMg (p = 0.015). However, on day 5, CE proliferation had a large increase and was deemed
statistically different compared to C (p = 0.042) and CMg (p = 0.025).

Figure 12. Luminescence of eluants collected at days 1, 3, and 5 from NIH3T3 fibroblasts on
membranes. Luminescence is indicative of increased cell count. ‘*’ denotes significant
difference (p < 0.05).

Viability staining images, shown in Figure 13 correlate with the findings in the
luminescence assay. CMg had little fibroblast infiltration into the membrane from days 1 – 5. C
group had little infiltration on day 1 and the cells remained spherical and did not spread. CE
membranes had a gradual increase in fibroblast infiltration, with more notable spreading and
growth and peaking at day 5. Cell spreading also occurred in CEMg membranes, but this
group’s performance peaked on day 1.
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Figure 13. Representative fluorescence images of C, CE, CMg, CEMg membranes at 1, 3, and
5 days cultured with NIH3T3 fibroblasts. Images were made by overlaying ‘live’ and ‘dead’
stained images of the same location on the membrane.

DISCUSSION
This work aimed to examine the potential of incorporating elastin and magnesium to
modify ESCMs for improved performance in burn wound applications. The addition of the elastin
was intended to enhance the compatibility and mechanical properties of the membranes, while
the presence of magnesium would support vascularization by enhancing endothelial cell
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recruitment and stimulation of VEGF. This initial work confirmed the increased bioactivity and
mechanical properties due to elastin incorporation.
Fiber diameter sizes did increase with the addition of elastin and MgNP. The increase in
fiber size was attributed to the effect adding multiple components had on the solution viscosity.
This effect aligns with findings in other work [77], [78]. This increase is not clinically substantial
as it should not compromise the advantageous characteristics of nanofibers. FTIR spectra
showed differences in elastin incorporated membranes vs. C and CMg membranes.
Incorporating elastin into ESCMs may compromise the hydrophobic treatment that prevents the
fibers from swelling in aqueous environments. This may be attributed to elastin’s hydrophilic
amino acids, which might overpower the hydrophobic group’s function [79]. CE and CEMg’s
degradation profiles can likely be attributed to this decreased hydrophobicity. As more water
infiltrates the CE and CEMg membranes, lysozyme has more access to regions within the
membrane that hydrophobic C and CMg may be preventing. This effect can be taken advantage
of in the future by manipulating elastin concentration to control membrane degradation rates.
The 24 hr release of all magnesium may be advantageous for burn wound applications
as it will deliver the total dosage at the beginning of the wound healing process, possibly
kickstarting healing. Further testing with endothelial cells must be done to determine the optimal
dose for inducing migration and promoting proliferation.
Elastin and magnesium incorporation did affect the mechanical properties compared to
the unmodified chitosan membranes. These results, however, are taken from post-treated
membranes, which might influence the outcomes. It is possible that we could further improve
the mechanical properties of the CE and CEMg membranes by introducing crosslinking.
Naturally, elastin relies on crosslinking to function, and researchers have begun to implement
this in some tissue engineering applications [32], [67], [68]. The soluble elastin may be in the
electrospinning solution uncrosslinked and therefore unable to contribute the expected elasticity,
which would explain the lack of improvement to maximum extension. This can be attributed to
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the manufacturer’s extraction and purification process or the interaction between the elastin and
strong TFA acid [80].
Overall, elastin incorporation improved the biocompatibility of ESCMs with fibroblasts.
CE and CEMg membranes, by far, exhibited the best proliferation rates, isolating elastin as a
critical contributor. This decreased hydrophobicity may be attractive to the fibroblasts, whereas
extremely hydrophobic materials (like CMg) are not [81], [82]. The immunofluorescence images
of CE and CEMg showed differences in cell morphology, notably increased cell spreading, that
may be attributed to elastin [83], [84].

CONCLUSION
This work shows the establishment of a robust, reproducible protocol successfully
incorporating both elastin and magnesium into ESCMs. Results show that elastin incorporation
significantly alters the material’s hydrophobicity following a treatment to preserve fiber
morphology in aqueous environments. The decreased hydrophobicity led to faster degradation
rates and improved fibroblast compatibility. Though some fine-tuning may be necessary
regarding magnesium dosage and elastin crosslinking, this work identifies chitosan-elastin
copolymer membranes loaded with magnesium nanoparticles as a potential platform for skin
tissue engineering.
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CHAPTER IV
FUTURE WORK AND RECOMMENDATIONS

The remainder of this work will be fine-tuning the elastin and magnesium components to
have optimal healing performance. Magnesium dosage studies can be conducted with differing
nanoparticle concentrations in electrospinning solutions. By translating this to in vitro cell
culture, an ideal magnesium amount can be established and optimized for performance.
As previously mentioned, tensile testing may have been affected by the hydrophobic
treatment of the membranes. The same test on untreated membranes would likely yield different
results.
Furthermore, the usage of nanoparticles may not be necessary. It is likely that with the
use of a strong acid like TFA, the nanoparticles are dissolved once in the electrospinning
solution. The incorporation of magnesium into the electrospun membrane may be achieved by
alternative methods.
To address the lack of mechanical contributions from elastin, an investigation into
crosslinking elastin should be started. Crosslinking may provide the material with increased %
elongation that was expected to be exhibited. Another route is the usage of an elastin-like
polypeptide over naturally derived elastin. Because synthesizing these elastin-like-polypeptides
provides greater control over structure and molecular weight, fabrication quality and spinnability
may be improved.
Finally, more in vitro tests are needed to assess the membranes’ performance with
keratinocytes (from the epidermis) and endothelial cells (to predict vascularization). Magnesium
dosage will likely play a role in endothelial cell recruitment. A co-culture of these cell types may
also be helpful to gain a better understanding of in vivo performance. If these are successful,
the membrane could be tested in a burn rodent model to understand in vivo efficacy. Further
optimization for in vivo efficacy may be needed before continuing to clinical trials.
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